|
Optimally tolerated dose of lapatinib in combination with docetaxel plus trastuzumab in first-line treatment of HER2-positive metastatic breast cancer |
|
|
|
Title: |
Optimally tolerated dose of lapatinib in combination with docetaxel plus trastuzumab in first-line treatment of HER2-positive metastatic breast cancer |
Author: |
Crown, J. Kennedy, M.J. Tresca, P. Marty, M. Espie, M. Burris, H.A. DeSilvio, M. Lau, M.R. Kothari, D. Koch, K.M. DiƩras, V. |
Appeared in: |
Annals of oncology |
Paging: |
Volume 24 () nr. 8 pages 2005-2011 |
Year: |
2013 |
Contents: |
|
Publisher: |
European Society for Medical Oncology |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|